company background image

Hironic KOSDAQ:A149980 Stock Report

Last Price


Market Cap







17 May, 2022


Company Financials
A149980 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health4/6

A149980 Stock Overview

Hironic Co., Ltd. provides aesthetic medical devices in South Korea and internationally.

Hironic Competitors













Price History & Performance

Summary of all time highs, changes and price drops for Hironic
Historical stock prices
Current Share Price₩9,280.00
52 Week High₩14,900.00
52 Week Low₩4,535.00
1 Month Change-22.67%
3 Month Change-11.62%
1 Year Change54.93%
3 Year Change23.08%
5 Year Change38.92%
Change since IPO-36.70%

Recent News & Updates

Shareholder Returns

A149980KR Medical EquipmentKR Market

Return vs Industry: A149980 exceeded the KR Medical Equipment industry which returned -6.2% over the past year.

Return vs Market: A149980 exceeded the KR Market which returned -15.8% over the past year.

Price Volatility

Is A149980's price volatile compared to industry and market?
A149980 volatility
A149980 Average Weekly Movement11.7%
Medical Equipment Industry Average Movement5.8%
Market Average Movement5.5%
10% most volatile stocks in KR Market10.3%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A149980 is more volatile than 90% of KR stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: A149980's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company


Hironic Co., Ltd. provides aesthetic medical devices in South Korea and internationally. It offers its products for the treatment of skin rejuvenation, face lifting, body shaping, acne, vaginal tightening, and hair transplantation and removal, as well as for the vascular and pigmented treatments. The company was founded in 2008 and is headquartered in Yongin-si, South Korea.

Hironic Fundamentals Summary

How do Hironic's earnings and revenue compare to its market cap?
A149980 fundamental statistics
Market Cap₩113.51b
Earnings (TTM)₩6.78b
Revenue (TTM)₩21.78b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A149980 income statement (TTM)
Cost of Revenue₩8.63b
Gross Profit₩13.15b
Other Expenses₩6.38b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date


Earnings per share (EPS)549.26
Gross Margin60.38%
Net Profit Margin31.11%
Debt/Equity Ratio4.7%

How did A149980 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio


Is Hironic undervalued compared to its fair value and its price relative to the market?

Valuation Score


Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: A149980 (₩9280) is trading above our estimate of fair value (₩1127.53)

Significantly Below Fair Value: A149980 is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: A149980 is poor value based on its PE Ratio (16.9x) compared to the KR Medical Equipment industry average (12.6x).

PE vs Market: A149980 is poor value based on its PE Ratio (16.9x) compared to the KR market (14.3x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A149980's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: A149980 is good value based on its PB Ratio (2x) compared to the KR Medical Equipment industry average (2.4x).

Future Growth

How is Hironic forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hironic has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Hironic performed over the past 5 years?

Past Performance Score


Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A149980 has a high level of non-cash earnings.

Growing Profit Margin: A149980's current net profit margins (31.1%) are higher than last year (23.3%).

Past Earnings Growth Analysis

Earnings Trend: A149980's earnings have grown significantly by 45.7% per year over the past 5 years.

Accelerating Growth: A149980's earnings growth over the past year (124.3%) exceeds its 5-year average (45.7% per year).

Earnings vs Industry: A149980 earnings growth over the past year (124.3%) exceeded the Medical Equipment industry 30.5%.

Return on Equity

High ROE: A149980's Return on Equity (12.1%) is considered low.

Financial Health

How is Hironic's financial position?

Financial Health Score


Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A149980's short term assets (₩37.6B) exceed its short term liabilities (₩3.1B).

Long Term Liabilities: A149980's short term assets (₩37.6B) exceed its long term liabilities (₩4.6B).

Debt to Equity History and Analysis

Debt Level: A149980 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A149980's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A149980's debt is not well covered by operating cash flow (16.1%).

Interest Coverage: A149980 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet


What is Hironic current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: A149980's dividend (0.53%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (0.84%).

High Dividend: A149980's dividend (0.53%) is low compared to the top 25% of dividend payers in the KR market (2.73%).

Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, A149980 has been paying a dividend for less than 10 years.

Growing Dividend: A149980's dividend payments have increased, but the company has only paid a dividend for 3 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (9%), A149980's dividend payments are thoroughly covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: A149980 is paying a dividend but the company has no free cash flows.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Hironic has no CEO, or we have no data on them.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Hironic Co., Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Hironic Co., Ltd.
  • Ticker: A149980
  • Exchange: KOSDAQ
  • Founded: 2008
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: ₩113.506b
  • Shares outstanding: 12.34m
  • Website:

Number of Employees


  • Hironic Co., Ltd.
  • U-Tower
  • 19th Floor
  • Yongin-Si
  • Gyeonggi-do
  • 16827
  • South Korea


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/17 00:00
End of Day Share Price2022/05/17 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.